Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Zambia

Abstract Background The 2022 malaria chemoprevention guidelines of the World Health Organization (WHO) recommend the provision of a full treatment course of an antimalarial medicine at predefined intervals, regardless of whether the child is infected with malaria, to prevent illness in moderate to h...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Rosario Martinez-Vega, Mike Chaponda, Andria Mousa, Jonathan Gwasupika, Enesia Banda Chaponda, Victor Daka, Sydney Mwanza, Mukuka Chipunga, Khalid B. Beshir, Ana Chopo-Pizarro, Harparkash Kaur, Lucy Okell, Helle Hansson, Emma Filtenborg Hocke, Michael Alifrangis, Roland Gosling, Cally Roper, Colin Sutherland, R. Matthew Chico
Format:	Artigo
Język:	Inglês
Wydane:	BMC 2025-11-01
Seria:	BMC Infectious Diseases
Hasła przedmiotowe:	Perennial malaria chemoprevention Intermittent preventive treatment Antimalarial resistance
Dostęp online:	https://doi.org/10.1186/s12879-025-11975-3
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!